Global Ganja Report

Over the past two years, the Latin American cannabis industry has "emerged from the shadows" to command the attention of international firms and investors. Legal cannabis sales within the region are on track to reach $125 million in 2018—but that figure is expected to rise to $12.7 billion by 2028.

A legal medical marijuana export industry is coming to Jamaica, which has just dispatched its first shipment of cannabis oil to Canada. Long famous for its contraband product, the island nation now has a Cannabis Licensing Authority to oversee legal cultivation.

With the DEA's rescheduling of Epidiolex, shares in the British manufacturer of the drug are soaring. But CBD—the actual cannabinoid that the product is based on—is to remain in the restrictive Scheudle 1.

Lesotho is a land-locked mountain kingdom in Africa that few in the outside world have heard of, but it punches above its weight where cannabis production is concerned. "Dagga" has long been a pillar of its economy. Now it is attracting international investment to grow cannabis for the global medical market. With cannabis just decriminalized in South Africa—which borders Lesotho on all sides, and is closely integrated with the kingdom—this is a promising sign for the entire region.

The global cannabis industry is increasingly dependent on factories in China's industrial zones—and fears being impacted by Trump's trade war with Beijing. Chinese pharmaceutical firms meanwhile explore potential applications of cannabis. Yet possession of herbaceous cannabis can land you before a firing squad in China. Human rights groups express alarm about the furious pace of executions in the People's Republic—outstripping the rest of the world combined. And drug offenses—including pot possession—top the country's capital crimes.

Among several cannabis-related bills that cleared California's state house before the last legislative session came to close is one that would lift the tax burden on medical marijuana providers. The bill is intended to again open space for "compassionate care," which was ironically squeezed out under California's adult-use regulation regime. 

With the North American Free Trade Agreement under renegotiation, Mexico's former president and born-again cannabis advocate Vicente Fox is calling for the new treaty to include provisions for legal cross-border commerce in cannabis. But of course the federal governments of both the US and Mexico prohibit cannabis—despite growing demands for legalization both sides of the border.

A new product is being plugged as containing CBD derived from humulus—that is, hops, the buds used as a bittering agent in beer. Some of the media hype has implied that this novel origin gets around the US federal stricture on the cannabinoid. But experts raise a skeptical eyebrow at the claim of hops-derived CBD. And in any event, the federal stricture is on the cannabinoid itself, regardless of how it is derived.